Noah Perin

Noah Perin is the current CEO at VIA Global Health. Noah has held this position since December 2014. Prior to that, they were a Commercialization Officer/Technology Portfolio Manager at PATH from July 2009 to December 2014. Before that, they were a Product Planner at Microsoft from October 2006 to June 2009.

Perin has also worked as a Managed Care Marketing at Genentech from May 2005 to August 2005 and as a Sr. Research Associate at Tularik (Amgen) from January 2002 to September 2003. Noah began their career as a Research Associate at Onyx Pharmaceuticals from May 1999 to December 2001.

Noah Perin has an MBA from Duke University's Fuqua School of Business, as well as a certificate in Health Sector Management. Noah also has an MPP from Duke University's Sanford School of Public Policy, with a concentration in Health Policy. Their undergraduate degree is in Molecular, Cellular and Developmental Biology from the University of California, Santa Cruz. Additionally, they have a fellowship from the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Finally, they have certification from PM4NGO in Project Management for Development Professionals.

Some direct reports include Mike Miranda - Head of Shipping & Logistics, Liliya Nikolova - Senior Marketing Manager, and Brinnon Mandel - VP for Strategic Partnerships.